The House Appropriations Committee approved a bill that would fund the Department of Health and Human Services through 2017, including the NIH, NCI and other related agencies.
The House Appropriations Subcommittee on Labor-HHS marked up a bipartisan spending bill July 6 that gives NIH a $1.25 billion increase in the 2017 fiscal year.
Gilman's resignation enabled him to retain the most precious of all privileges: the ability to look at himself in the mirror.
Stanford Cancer Institute earned the NCI Comprehensive Cancer Center designation, becoming the eighth institution in California to earn this highest level of recognition.
A transcript of Biden’s speech at the National Cancer Moonshot Summit at Howard University.
Richard Pazdur, currently the director of the FDA Office of Hematology and Oncology Products, will serve as acting director of the newly formed FDA Oncology Center of Excellence.
Vice President Joe Biden announced the formation of the FDA Oncology Center of Excellence, which is intended to consolidate the agency's cancer portfolio and streamline regulatory pathways for cancer-related drugs, biologics, and devices.
After a year of trying to understand the biology and politics of cancer, Vice President Joe Biden admits that he has a stronger grasp on the nuts and bolts of Washington than the evolutionary mysteries known collectively as cancer.
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month. For further information, contact the principal investigator listed.
A secondary analysis of the phase III ASPIRE trial that showed Kyprolis (carfilzomib) for Injection, in combination with lenalidomide and dexamethasone, improved progression-free survival and overall response rate, compared to lenalidomide and dexamethasone alone, in patients with relapsed multiple myeloma with early disease progression after initial therapy or transplant.
